- The Daily Advantage
- Posts
- Digital Twins?
Digital Twins?
Gen Z's New Job Outlook, New Hire Increases Petco Stock, and more...

THE PROFITS💸
Digital Twins?
Gen Z’s New Job Outlook
New Hire Increases Petco Stock
Read Time: 2.5 mins
THE BIG PROFITS💸
Digital Twins?
Digital Twins Skyrocket the Healthcare Market.
Gen Z’s Job Outlooks
Gen Z is Reconsidering their Future.
Petco Stocks Rise after new Hire
Retail Experience takes the Cake… or fetches the Ball.
Digital Twins?

Man is looking at himself… his digital self. Depicted by AI.
Digital Twins?
A digital twin is a virtual replica of a physical entity, whether it's an avatar in a Zoom meeting, a postmortem persona, or a pair of sneakers.
Even more exciting than texting with the dead, digital twins could one day save lives.
The global digital twins healthcare market is expected to soar to $21.1 billion by 2028, up from $1.6 billion in 2023. Startups, government agencies, and academic institutions are heavily investing in this technology, according to The Wall Street Journal.
New discovery of digital twins has the healthcare market soaring and will be worth $21.1 billion by 2028.
Gen Z’s Job Outlook
College student is frightened for future. Depicted by AI
Gen Z’s Job Outlook
Gen Z is shifting career aspirations from highly paid tech roles to health care and government jobs, valuing stability amid recent tech layoffs and AI concerns, according to Business Insider. Applications for government jobs doubled in 2023, while those for tech companies dropped by 19%.
Google, once the top dream employer in 2017, fell to No. 7 in 2024, with St. Jude Children’s Research Hospital now leading the most desirable industry.
The FBI, NASA, and the CIA are now among the top-ranked dream employers for Gen Z.
Health care institutions like the Mayo Clinic and Health Care Service Corp. have risen in popularity among job seekers.
Economic shift has Gen Z reconsidering their dream jobs and interplanetary discovery advancements and healthcare have risen in popularity.
Story Title
New Petco CEO walking his new dog and cat with experience. Depicted by AI.
Petco Stocks Rise After New CEO Hire
Petco announced late Wednesday that Joel Anderson will be its new CEO, a move analysts see as crucial for the company's revitalization. Anderson is joining from Five Below, a discount retailer, whose shares fell significantly after the news.
Petco (WOOF) shares rose by over 3% to just under $4 on Thursday, while Five Below (FIVE) shares dropped 25% on Wednesday and an additional 5% on Thursday.
Anderson will start his role on July 29.
Wedbush analysts praised Anderson's "wealth of retail experience" and raised their price target for Petco from $4 to $5. Anderson, who has nearly a decade of experience as CEO of Five Below, has also held executive positions at Walmart (WMT) and other retailers. Petco's shares have increased more than 20% this year, recovering from spring lows below $1.50.
Petco hires their new CEO Joel Anderson and their Stock rose due to his past experience in retail.
Favorite Corporate Buzz Word or Phrase Poll
Favorite Corporate Buzz Word or Phrase Poll |
Trending Now
Ford trails away from EV Manufacturing: Ford is increasing production of its Super Duty pickup trucks at a Canadian plant originally intended for electric vehicle (EV) manufacturing, investing $2.3 billion in assembly and stamping operations at Oakville, Ontario. CEO Jim Farley attributed the expansion to high demand for Super Duty trucks, despite earlier plans for the plant to focus on EVs, including three-row electric SUVs delayed until 2027. Ford's stock rose 1.8% to $14.74 on Thursday, reflecting a 20% increase in value this year following the announcement.
Infosys Expecting Growth: Infosys has raised its fiscal 2025 revenue forecast to grow between 3% and 4%, marking an improvement from its previous outlook. The IT firm exceeded expectations with quarterly revenue up 2.5% in constant currency to $4.71 billion and net profit rising 5.4% to $763 million after minority interest.
Novartis Decline Despite Increase: Novartis reported second-quarter net sales and adjusted profit that surpassed analysts' forecasts. The pharmaceutical company also raised its full-year core operating income outlook for the second consecutive quarter, now anticipating fiscal 2024 core operating income growth in the mid- to high-teen percentage range, up from its previous forecast of low-double-digit to mid-teen growth.
Quiz
Which of these is the real painting?

Which is Andy Warhol's "Shot Sage Blue Marilyn" (1964)?Christie's |

What Was Your Profit From This Article? |